Word: arced
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
...theguiding hands of the faculty. Will any of us everforget John Finley '28 in his waltz across thestage as he described Agamemnon, (he laterdescribed an Eliot House senior as a cross betweenAchilles and Harry Truman), pivoting as he reachedstage end and swirling the cord of his microphonein a deft arc...
...virus similar to herpes called Human T-Lymphotrophic Virus Type III (HTLV-III) which infects the white blood cells. But while the virus has been linked to AIDS, it does not always produce the deadly and debilitating disease. Sometimes, it causes a milder illness known as AIDS-Related Complex (ARC) or has absolutely no effect...
...Monday, nearly twice what it was one year ago. So far 11,384 people have died after contracting the illness. AIDS has been primarily associated with gay men, intravenous drug users and people who need frequent blood transfusions. By unofficial estimates, the number of ARC cases could range as high as 50,000, and the number of asymptomatic carriers--those who have been infected but have not displayed symptoms--could be as high as 2 million. No one is known yet to have recovered from AIDS...
...cutting edge of Hirsch and Groopman's research. They are azidothymidine (AZT), a synthetic drug that was originally designed to combat cancer, and alpha interferon, a relatively new, genetically-engineered substance. Hirsch has just concluded a two-year placebo-controlled, double-blind study of 24 AIDS and ARC patients treated with the interferon, whose results will be revealed in June. In addition, both Hirsch and Groopman are participating in a nation-wide study of AZT in AIDS and ARC patients. Hirsch has already enrolled more than 100 patients, while Groopman is in the process of selecting...
...problems plague the researchers in their quest for an effective and non-toxic anti-viral drug--some of them not involving science. Groopman has encountered peculiar problems in the AZT study. "There is tremendous political pressure," Groopman says. He only has room for 20 patients while 60 AIDS and ARC patients want to take part in the experiment. So he will choose patients only on a "first-come, first serve basis...